Hinge Health Inc. Class A Common Stock vs PepsiCo, Inc. — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.47B), while PepsiCo, Inc. trades at $131.45 (market cap $176.16B). The key difference: PepsiCo, Inc. is far larger — about 20.8× Hinge Health Inc. Class A Common Stock's market cap, and PepsiCo, Inc. pays a 4.58% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and PepsiCo, Inc. for 108 Days on average.
| HNGE | PEP | |
|---|---|---|
Market Cap | $8.47B | $176.16B |
Volume | 1,624,526 | 9,536,018 |
Sector | Health | Consumer Staples |
52-Week High | $105.14 | $170.44 |
52-Week Low | $31.17 | $123.64 |
Typical Hold Time | 0 Days | 108 Days |
Enterprise Value | $8.09B | $216.88B |
Dividend Yield | — | 4.58% |
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
PepsiCo (PEP) trades at $127.28, up 0.44% today, with a bearish technical signal but strong fundamentals including four consecutive quarterly EPS beats. The stock shows a P/E of 16.01 and a net income margin of 11.09%, supported by robust cash flow from operations of $12.09B in 2025. Recent news highlights price adjustments for snacks like Doritos to address consumer pushback on high prices.
The outlook is cautiously optimistic with a consensus price target of $142.38 implying 12% upside, though technical indicators suggest near-term resistance. Risks include competitive pressures and sensitivity to consumer spending trends, but the company's consistent profitability and dividend payments provide stability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →